Infulid (Linezolid 600 mg Tablets)

Overview:

INFULID Tablets contains Linezolid. It has activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP).

box_infulid


Linezolid which is a synthetic antibacterial agent of the oxazolidinone class.
Antibacterial.

INFULID Tablets can be used in the treatment of the following conditions:

  • Nosocomial and community acquired pneumonia
  • Complicated and uncomplicated skin and skin structure infections including MRSA
  • Diabetic foot infections
  • Vancomycin-Resistant Enterococcus Faecium Infections.
  • Multi-drug resistant tuberculosis & extensively drug-resistant tuberculosis.


Adults and children (12yrs and above): One INFULID Tablet twice a day for 10-14 days (14-28 days for VRE infections). One INFULID Tablet twice a day for 4-6 weeks followed by one INFULID Tablet a day for extensively drug resistant tuberculosis.

Linezolid selectively inhibits bacterial protein synthesis through binding to sites on the bacterial ribosome and prevents the formation of a functional 70S-initiation complex. Linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process.